|
|
Effect of thumbtack needling therapy on clinical symptoms and inflammatory factors of unstable angina pectoris with syndrome of blood stasis due to qi deficiency in patients with coronary heart disease after percutaneous coronary intervention |
DAI Yu YANG Jing LEI Dongxue LIU Huaying |
Department of Cardiovascular Medicine, Tangshan Traditional Chinese Medicine Hospital, Hebei Province, Tangshan 063000, China
|
|
|
Abstract Objective To investigate the effect of thumbtack needling therapy on clinical symptoms and inflammatory factors in unstable angina pectoris with syndrome of blood stasis due to qi deficiency in patients with coronary heart disease after percutaneous coronary intervention (PCI). Methods According to the random number table method, 112 unstable angina pectoris patients with syndrome of blood stasis due to qi deficiency with coronary heart disease after PCI in Tangshan Traditional Chinese Medicine Hospital in Hebei Province from March 2021 to March 2022 were divided into control group (56 cases) and study group (56 cases). The control group was treated with routine treatment, and the study group was treated with routine treatment and thumbtack needling therapy. Both two groups were treated for one month. The curative effect was compared between the two groups, and the traditional Chinese medicine syndrome score, inflammatory factor levels were compared between the two groups before and after treatment, and the occurrence of adverse events was recorded. Results The clinical efficacy of the study group was better than that of the control group, and the difference was statistically significant (P<0.05). After treatment, the scores of chest stabbing pain, chest distress, shortness of breath, malaise, palpitations, pale complexion, and burnout in the two groups were lower than those before treatment, and those in the study group were lower than those in the control group, and the differences were statistically significant (P<0.05). After treatment, the levels of serum high-sensitivity C-reactive protein, human cartilage glycoprotein, and interleukin-6 in the two groups were lower than those before treatment, and those in the study group were lower than those in the control group, and the differences were statistically significant (P<0.05). No serious adverse events occurred in the two groups during the treatment. Conclusion The thumbtack needling therapy can effectively improve the clinical symptoms of unstable angina pectoris with syndrome of blood stasis due to qi deficiency in patients with coronary heart disease after PCI, reduce the levels of inflammatory factors, and has high safety.
|
|
|
|
|
[1] 时之秀,杜训松,曹洁.老年冠心病患者PCI术后主要心脑血管不良事件发生情况及影响因素分析[J].临床心血管病杂志,2022,38(2):132-136.
[2] 周琦,柯玲,阮科,等.系统炎症因子预测老年冠心病PCI术后主要不良心脑血管事件的价值[J].临床心血管病杂志,2022,38(2):118-123.
[3] 董晨艳,陈海燕,李源.复方丹参滴丸联合替格瑞洛治疗冠心病PCI术后心绞痛的临床疗效[J].中西医结合心脑血管病杂志,2022,20(2):292-294.
[4] 刘子贤,包宇,乔利杰,等.基于数据挖掘探讨中医药治疗冠心病PCI术后再发心绞痛气虚血瘀证的用药规律[J].中西医结合心脑血管病杂志,2022,20(19):3508-3514.
[5] 李永聪,李菁,周丽,等.揿针疗法联合心脉通贴散穴位贴敷干预对不稳定性心绞痛患者的疗效观察[J].护理实践与研究,2020,17(23):52-54.
[6] 葛均波,徐永健.内科学[M].北京:人民卫生出版社,2013:220-257.
[7] 国家中医药管理局.胸痹心痛的诊断依据、证候分类、疗效评定——中华人民共和国中医药行业标准《中医内科病证诊断疗效标准》(ZY/T001.1-94)[J].辽宁中医药大学学报,2016,18(7):32.
[8] Van Nguyen H,Khuong LQ,Nguyen AT,et al. Changes in,and predictors of,quality of life among patients with unstable angina after percutaneous coronary intervention [J]. J Eval Clin Pract,2021,27(2):325-332.
[9] Ma XJ,Duan WH,Zhang Y,et al. Combination of Activating Blood Circulation and Detoxifying Chinese Medicines Played an Anti-Inflammatory Role in Unstable Angina Patients after Percutaneous Coronary Intervention:A Multicenter,Open- Labeled,Randomized Controlled Trial [J]. Chin J Integr Med, 2021,27(11):803-810.
[10] Tang XF,Song Y,Xu JJ,et al. Effect of sex difference in clinical presentation(stable coronary artery disease vs unstable angina pectoris or non-ST-elevation myocardial infarction vs ST-elevation myocardial infarction)on 2-year outcomes in patients undergoing percutaneous coronary intervention [J]. J Interv Cardiol,2018,31(1):5-14.
[11] 林昌,袁先琢,高发林,等.PCI术后再发心绞痛患者中医证候与冠脉病变关系及危险因素分析[J].中国中医急症,2022,31(3):450-453.
[12] 李明伟,杨文学,李敏,等.杨明会教授从阳微阴弦论治冠心病PCI术后心绞痛的经验[J].中国中西医结合急救杂志,2022,29(4):476-478.
[13] 陈颖,薛崇祥,杨德爽,等.基于Meta分析探讨益气活血类中药防治冠心病PCI术后再狭窄的优势[J].中西医结合心脑血管病杂志,2022,20(14):2497-2507.
[14] 赵维哲,李杰,王玥,等.基于文献研究分析揿针在肿瘤辅助治疗中的应用现状及展望[J].辽宁中医杂志,2021,48(5):34-37,后插3.
[15] 韩名媛,孙忠人,尹洪娜,等.揿针治疗过敏性鼻炎的研究进展[J].中国中医急症,2021,30(10):1859-1862.
[16] 梁春玲,刘祖发,张辰浩,等.揿针治疗不稳定型心绞痛介入术后心肌损伤临床研究[J].陕西中医,2020,41(3):383-386.
[17] 项少茜,胡晓雷.腕踝针联合揿针疗法治疗腰腿痛患者的临床效果[J].中国医药导报,2022,19(16):147-150.
[18] 周全,田书芳,肖慧,等.腕踝针结合揿针治疗枕神经痛42例[J].中国针灸,2023,43(2):207-208.
[19] 李梦兰,梁宾,曹树正,等.系统性炎症指数在冠心病中的临床意义及诊断价值研究[J].国际检验医学杂志,2021,42(19):2329-2332.
[20] 李金宝,杨国华,黄超联,等.四参护心汤对介入治疗术后心绞痛气虚血瘀证患者生活质量及炎症因子的影响[J].北京中医药,2022,41(2):186-189.
[21] 张雅婷,郭芳云.血清cTnT、hs-CRP在冠心病PCI术后患者中的表达水平及其对预后的预测价值[J].检验医学与临床,2021,18(20):2964-2966.
[22] 李俊,秦海霞,孟令东.冠心病患者血清胱抑素C及高敏C反应蛋白水平与冠状动脉狭窄程度的相关性研究[J].中国医药,2021,16(1):38-41.
[22] 惠波,蔡宇豪,邵一兵.冠心病患者血液循环中易损斑块相关预测指标分析[J].兰州大学学报(医学版),2022, 48(10):76-80.
[23] Ma CY,Xu ZY,Wang SP,et al. Change of Inflammatory Factors in Patients with Acute Coronary Syndrome [J]. Chin Med J(Engl),2018,131(12):1444-1449.
[24] 蔡旭,肖剑伟,程钒钒,等.揿针治疗类风湿关节炎的临床疗效及对血清炎症因子的影响[J].河北中医,2022, 44(6):997-1001.
[25] 于少敏,张少鹏,郑昊钰,等.砭贴或揿针百会与内关对模拟高原环境大鼠血清炎性因子及脑组织血管内皮生长因子的影响[J].中华中医药杂志,2020,35(7):3708- 3710. |
|
|
|